Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
6 February 2026: Aktieselskabet Schouw & Co. (the "Issuer") has initiated a summons for a Written Resolution (the "Summons") pursuant to the bond terms dated 14 June 2024 (as amended) (the "Bond...
-
Hydros resultat for fjerde kvartal 2025 blir offentliggjort 13. februar 2026 kl. 07.00 CET (01.00 EST, 06.00 GMT). Hydros årsrapport 2025 blir offentliggjort kl 08.00 CET (02:00 EST, 07.00 GMT) samme...
-
Hydro's fourth quarter results 2025 will be released at 07:00 CET (01:00 EDT, 06:00 UTC/GMT) on February 13, 2025. The integrated annual report 2025 will be released the same day at 08:00 CET (02:00...
-
Telenor går inn i 2026 med sterk nordisk vekst, solid finansiell posisjon og en forenklet portefølje, i tråd med ambisjonene fra kapitalmarkedsdagen. – Resultatene for 2025 viser at vi leverer som...
-
Telenor enters 2026 with strong Nordic growth, a solid financial position, and a simplified portfolio in line with the ambitions presented at the Capital Markets Day. “The results for 2025 show that...
-
(Oslo, Norway, 5 February 2025) Hexagon Purus ASA ("Hexagon Purus" or the “Company”), a world leading manufacturer of zero-emission mobility and infrastructure solutions, has through one of its wholly...
-
Oslo, 5 February 2026: On the basis of the authorization granted by the General Meeting on 29 April 2025 for the Board of Directors of Zelluna ASA (the “Company”, OSE ticker “ZLNA”) to issue shares to...
-
GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million. Reference is made to the stock exchange announcement published on 27 January 2026...
-
International Petroleum Corporation ("IPC" or the "Corporation") (TSX, Nasdaq Stockholm: IPCO) announces that the Swedish Financial Supervisory Authority today approved the prospectus in connection...
-
Oslo, Norway, 5 February 2026 Vistin Pharma ASA will release its fourth quarter and preliminary 2025 results on Thursday 12th of February 2025. Vistin Pharma will host a conference call for all...